Ipca Laboratories Limited (BOM:524494)
India · Delayed Price · Currency is INR 1,939.15
-7.00 (-0.36%)
At close: Oct 7, 2026
Ipca Laboratories Market Cap
Ipca Laboratories has a market cap or net worth of 491.81 billion as of October 7, 2026. Its market cap has increased by 46.50% in one year.
Market Cap
491.81B
Enterprise Value
502.54B
Revenue
101.26B
Ranking
n/a
PE Ratio
37.55
Stock Price
1,939.15
ChartMarket Cap Chart
Since June 12, 2002, Ipca Laboratories's market cap has increased from 3.22B to 491.81B, an increase of 15,179.40%. That is a compound annual growth rate of 22.95%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 7, 2026 | 491.81B | 36.62% |
| Dec 31, 2025 | 359.98B | -16.30% |
| Dec 31, 2024 | 430.08B | 52.29% |
| Dec 29, 2023 | 282.41B | 32.03% |
| Dec 30, 2022 | 213.90B | -22.18% |
| Dec 31, 2021 | 274.86B | -1.01% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Torrent Pharmaceuticals | 1.81T |
| Dr. Reddy's Laboratories | 999.66B |
| Lupin | 927.73B |
| Abbott India | 570.16B |
| GlaxoSmithKline Pharmaceuticals | 470.02B |
| J. B. Chemicals & Pharmaceuticals | 387.31B |
| Granules India | 203.39B |
| Caplin Point Laboratories | 200.09B |